[HTML][HTML] A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients
A El-Beshlawy, AA Salama, MR El-Masry… - Scientific Reports, 2020 - nature.com
The development of hemolytic erythrocyte alloantibodies and autoantibodies complicates
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …
A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients.
A El-Beshlawy, AA Salama, MR El-Masry… - Scientific …, 2020 - search.ebscohost.com
The development of hemolytic erythrocyte alloantibodies and autoantibodies complicates
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …
[HTML][HTML] A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients
A El-Beshlawy, AA Salama, MR El-Masry… - Scientific …, 2020 - ncbi.nlm.nih.gov
The development of hemolytic erythrocyte alloantibodies and autoantibodies complicates
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …
A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients
A El-Beshlawy, AA Salama, MR El-Masry… - Scientific …, 2020 - pubmed.ncbi.nlm.nih.gov
The development of hemolytic erythrocyte alloantibodies and autoantibodies complicates
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …